Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kamb

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Iscience|May 27, 2024
NOT gated T cells that selectively target EGFR and other widely expressed tumor antigensJulyun Oh, Charles Kirsh, Jing-Ping Hsin, et al.
Plos One|October 14, 2010
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathwaysRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Science (New York, N.Y.)|June 27, 2015
SCIENTIFIC INTEGRITY. Self-correction in science at workBruce Alberts, Ralph J Cicerone, Stephen E Fienberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2020
Re-examination of MAGE-A3 as a T-cell Therapeutic TargetAaron D Martin, Xueyin Wang, Mark L Sandberg, et al.
Frontiers in Immunology|February 12, 2024
Geometric parameters that affect the behavior of logic-gated CAR T cellsAlexander C Partin, Richele Bruno, Sanam Shafaattalab, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Genetics|March 29, 2003
Genetic selection for modulators of a retinoic-acid-responsive reporter in human cellsBurt Richards, Jon Karpilow, Christine Dunn, et al.
Molecular Therapy Oncolytics|November 16, 2022
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigenJee-Young Mock, Aaron Winters, Timothy P Riley, et al.
Molecular Immunology|August 22, 2021
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similaritiesXueyin Wang, Aaron D Martin, Kathleen R Negri, et al.
Toxicology and Applied Pharmacology|January 27, 2022
A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapyXueyin Wang, Lu Min Wong, Michele E McElvain, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Iscience|May 27, 2024
NOT gated T cells that selectively target EGFR and other widely expressed tumor antigensJulyun Oh, Charles Kirsh, Jing-Ping Hsin, et al.
Plos One|October 14, 2010
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathwaysRoy Blum, Rashmi Gupta, Patricia E Burger, et al.
Science (New York, N.Y.)|June 27, 2015
SCIENTIFIC INTEGRITY. Self-correction in science at workBruce Alberts, Ralph J Cicerone, Stephen E Fienberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2020
Re-examination of MAGE-A3 as a T-cell Therapeutic TargetAaron D Martin, Xueyin Wang, Mark L Sandberg, et al.
Frontiers in Immunology|February 12, 2024
Geometric parameters that affect the behavior of logic-gated CAR T cellsAlexander C Partin, Richele Bruno, Sanam Shafaattalab, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Genetics|March 29, 2003
Genetic selection for modulators of a retinoic-acid-responsive reporter in human cellsBurt Richards, Jon Karpilow, Christine Dunn, et al.
Molecular Therapy Oncolytics|November 16, 2022
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigenJee-Young Mock, Aaron Winters, Timothy P Riley, et al.
Molecular Immunology|August 22, 2021
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similaritiesXueyin Wang, Aaron D Martin, Kathleen R Negri, et al.
Toxicology and Applied Pharmacology|January 27, 2022
A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapyXueyin Wang, Lu Min Wong, Michele E McElvain, et al.
Pageof 5